Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Plos One|November 4, 2022
ANIPHI: An innovative pedagogical platform based on the Delphi method to support animal welfare teachingAna C L Vieira, Michel Vidal, Jean-Baptiste Menassol, et al.
Journal of the American Chemical Society|May 1, 2024
Free-Standing DNA Origami Superlattice to Facilitate Cryo-EM Visualization of Membrane VesiclesNesrine Aissaoui, Allan Mills, Josephine Lai-Kee-Him, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2016
Clinical pharmacology, drug-drug interactions and safety of pazopanib: a reviewPascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, et al.
Clinical Pharmacokinetics|August 11, 2018
Clinical Pharmacokinetics and Pharmacodynamics of DabrafenibAlicja Puszkiel, Gaëlle Noé, Audrey Bellesoeur, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 9, 2020
Simultaneous quantification of dabrafenib, hydroxy-dabrafenib and trametinib in human plasma by liquid chromatography-tandem mass spectrometryDavid Balakirouchenane, Nihel Khoudour, Sarah Guégan, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2023
Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid CancerDavid Balakirouchenane, Romain Seban, Lionel Groussin, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 13, 2018
Lithium effects on serine-threonine kinases activity: High throughput kinomic profiling of lymphoblastoid cell lines from excellent-responders and non-responders bipolar patientsJeverson Moreira, Gaëlle Noé, Savithri Rangarajan, et al.
Biochemical Pharmacology|May 6, 2008
The cytotoxicity of a Grb2-SH3 inhibitor in Bcr-Abl positive K562 cellsYun-Bin Ye, Jian-Yin Lin, Qiang Chen, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 3, 2023
LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing's SyndromeDavid Balakirouchenane, Axelle Vasseur, Fidéline Bonnet-Serrano, et al.
Pageof 14